http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2553038-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
filingDate 2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_562d66b05767dc51a05f5797322f4e86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5cead4197a9ddd80ee641d3f527d799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffe1d5a2c1ef0862dcbc7bb2101326eb
publicationDate 2005-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2553038-A1
titleOfInvention Compositions substantially free of galactomannan containing piperacillin and tazobactam
abstract The invention pertains to pharmaceutical compositions of Zosyn® having substantially free or reduced levels of galactomannan and processes to prepare said pharmaceutical compositions.
priorityDate 2004-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453284053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90477033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9918881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415751209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450566468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7057887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452875588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425729889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413934125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453505587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723671

Total number of triples: 55.